Genomic variation in seven Khoe-San groups reveals adaptation and complex African history CM Schlebusch, P Skoglund, P Sjödin, LM Gattepaille, D Hernandez, ... Science 338 (6105), 374-379, 2012 | 471 | 2012 |
Human adaptation to arsenic-rich environments CM Schlebusch, LM Gattepaille, K Engström, M Vahter, M Jakobsson, ... Molecular biology and evolution 32 (6), 1544-1555, 2015 | 159 | 2015 |
Inferring population size changes with sequence and SNP data: lessons from human bottlenecks LM Gattepaille, M Jakobsson, MGB Blum Heredity 110 (5), 409-419, 2013 | 101 | 2013 |
Khoe-San Genomes Reveal Unique Variation and Confirm the Deepest Population Divergence in Homo sapiens CM Schlebusch, P Sjödin, G Breton, T Günther, T Naidoo, N Hollfelder, ... Molecular biology and evolution 37 (10), 2944-2954, 2020 | 78 | 2020 |
Disproportionality analysis for pharmacovigilance signal detection in small databases or subsets: recommendations for limiting false-positive associations O Caster, Y Aoki, LM Gattepaille, B Grundmark Drug Safety 43, 479-487, 2020 | 78 | 2020 |
Robustness analysis and behavior discrimination in enzymatic reaction networks A Donzé, E Fanchon, LM Gattepaille, O Maler, P Tracqui PloS one 6 (9), e24246, 2011 | 78 | 2011 |
Demographic inferences using short‐read genomic data in an approximate Bayesian computation framework: In silico evaluation of power, biases and proof of concept in Atlantic walrus ABA Shafer, LM Gattepaille, REA Stewart, JBW Wolf Molecular Ecology 24 (2), 328-345, 2015 | 66 | 2015 |
Combining markers into haplotypes can improve population structure inference LM Gattepaille, M Jakobsson Genetics 190 (1), 159-174, 2012 | 62 | 2012 |
Inferring past effective population size from distributions of coalescent times L Gattepaille, T Günther, M Jakobsson Genetics 204 (3), 1191-1206, 2016 | 27 | 2016 |
Adverse events in twitter-development of a benchmark reference dataset: results from IMI WEB-RADR J Dietrich, LM Gattepaille, BA Grum, L Jiri, M Lerch, D Sartori, ... Drug safety 43, 467-478, 2020 | 21 | 2020 |
Prospective evaluation of adverse event recognition systems in Twitter: results from the Web-RADR project LM Gattepaille, S Hedfors Vidlin, T Bergvall, CE Pierce, J Ellenius Drug safety 43, 797-808, 2020 | 18 | 2020 |
HaploPOP: a software that improves population assignment by combining markers into haplotypes N Duforet-Frebourg, LM Gattepaille, MGB Blum, M Jakobsson BMC bioinformatics 16, 1-8, 2015 | 11 | 2015 |
Using the WHO database of spontaneous reports to build joint vector representations of drugs and adverse drug reactions, a promising avenue for pharmacovigilance LM Gattepaille 2019 IEEE international conference on healthcare informatics (ICHI), 1-6, 2019 | 5 | 2019 |
Reports for herbal medicines in the global suspected ADR database VigiBase F van Hunsel, LM Gattepaille, C Westerberg, J Barnes Pharmacovigilance for Herbal and Traditional Medicines: Advances, Challenges …, 2022 | 4 | 2022 |
How Far Can We Go with Just Out-of-the-box BERT Models? L Gattepaille Proceedings of the Fifth Social Media Mining for Health Applications …, 2020 | 4 | 2020 |
De Jongh M, Singleton A, Blum MGB, et al CM Schlebusch, P Skoglund, P Sjodin, LM Gattepaille, D Hernandez, ... Genomic Variation in Seven Khoe-26 San Groups Reveals Adaptation and Complex …, 2012 | 4 | 2012 |
Adverse event recognition in tweets: results from a WEB-RADAR project L Gattepaille, SH Vidlin, T Bergvall, J Ellenius DRUG SAFETY 41 (11), 1160-1161, 2018 | 2 | 2018 |
Automated Drug Coding Using Artificial Intelligence: An Evaluation of WHODrug Koda on Adverse Event Reports EL Meldau, S Bista, E Rofors, LM Gattepaille Drug Safety 45 (5), 549-561, 2022 | 1 | 2022 |
Automatic detection and removal of personal identifiers in case narratives using deep learning EL Meldau, SH Vidlin, L Gattepaille, H Taavola, L Sandberg, Y Aoki, ... DRUG SAFETY 41 (11), 1141-1141, 2018 | 1 | 2018 |
Probabilistic record linkage to detect duplicated content in twitter prior to pharmacovigilance analyses T Bergvall, L Gattepaille, S Vidlin, N Noren PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 347-347, 2018 | 1 | 2018 |